Clinical Characteristics of The First IMLYGIC™ Patients With Unresectable Stage IIIB-IVM1a Melanoma Treated in Routine Clinical Practice, in Selected European Countries (20140413)

First published 26/01/2017

Last updated 22/02/2024

EU PAS number:

EUPAS17410

Study

Finalised

Documents

Study protocol

Initial protocol

01.02.05 Special Protocol Ver 1.0 2016-10-28 English

English (451.13 KB - PDF) View document

Updated protocol

20140413 01.02.06 Public Redacted Protocol Ver 1.0 English

First published: 22/02/2024

English (227.41 KB - PDF) View document

Study results

20140413 Observational Research Study Report Abstract

English (194.6 KB - PDF) View document

Study report

Other information

Secondary tabs